528 related articles for article (PubMed ID: 11752153)
1. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
Katich SC; Zerfass-Thome K; Hoffmann I
Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986
[TBL] [Abstract][Full Text] [Related]
3. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
4. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
5. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Helt AM; Galloway DA
J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
7. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.
Naeger LK; Goodwin EC; Hwang ES; DeFilippis RA; Zhang H; DiMaio D
Cell Growth Differ; 1999 Jun; 10(6):413-22. PubMed ID: 10392903
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
Helt AM; Funk JO; Galloway DA
J Virol; 2002 Oct; 76(20):10559-68. PubMed ID: 12239337
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
Ruesch MN; Laimins LA
Virology; 1998 Oct; 250(1):19-29. PubMed ID: 9770416
[TBL] [Abstract][Full Text] [Related]
10. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16.
Schulze A; Mannhardt B; Zerfass-Thome K; Zwerschke W; Jansen-Dürr P
J Virol; 1998 Mar; 72(3):2323-34. PubMed ID: 9499093
[TBL] [Abstract][Full Text] [Related]
11. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest.
Iavarone A; Massagué J
Mol Cell Biol; 1999 Jan; 19(1):916-22. PubMed ID: 9858615
[TBL] [Abstract][Full Text] [Related]
12. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31.
Longworth MS; Laimins LA
J Virol; 2004 Apr; 78(7):3533-41. PubMed ID: 15016876
[TBL] [Abstract][Full Text] [Related]
13. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
14. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
Jones DL; Alani RM; Münger K
Genes Dev; 1997 Aug; 11(16):2101-11. PubMed ID: 9284049
[TBL] [Abstract][Full Text] [Related]
15. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
16. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
Koziczak M; Müller H; Helin K; Nagamine Y
Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
Zhang B; Laribee RN; Klemsz MJ; Roman A
Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
Jones DL; Münger K
J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
[TBL] [Abstract][Full Text] [Related]
20. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.
Zhang HS; Gavin M; Dahiya A; Postigo AA; Ma D; Luo RX; Harbour JW; Dean DC
Cell; 2000 Mar; 101(1):79-89. PubMed ID: 10778858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
